Mild impairment of renal function (shrunken pore syndrome) is associated with increased risk for future surgery for aortic stenosis

References

• Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305.
   PubMed Web of Science ®Google Scholar
• Kim D, Shim CY, Hong GR, et al. Effect of end-stage renal disease on rate of progression of aortic stenosis. Am J Cardiol. 2016;117(12):1972–1977.
   PubMed Web of Science ®Google Scholar
• Soveri I, Berg UB, Bjork J, et al. Measuring GFR: a systematic review. Am J Kidney Dis. 2014;64(3):411–424.
   PubMed Web of Science ®Google Scholar
• Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352(20):2049–2060.
   PubMed Web of Science ®Google Scholar
• Grubb A, Lindstrom V, Jonsson M, et al. Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken pore syndrome'. Scand J Clin Lab Invest. 2015;75(4):333–340.
   PubMed Web of Science ®Google Scholar
• Christensson A, Grubb A, Molvin J, et al. The shrunken pore syndrome is associated with declined right ventricular systolic function in a heart failure population – the HARVEST study. Scand J Clin Lab Invest. 2016;76(7):568–574.
   PubMed Web of Science ®Google Scholar
• Dardashti A, Nozohoor S, Grubb A, et al. Shrunken Pore Syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting. Scand J Clin Lab Invest. 2016;76(1):74–81.
   PubMed Web of Science ®Google Scholar
• Purde MT, Nock S, Risch L, et al. The cystatin C/creatinine ratio, a marker of glomerular filtration quality: associated factors, reference intervals, and prediction of morbidity and mortality in healthy seniors. Transl Res. 2016;169:80–90.e1–2.
   PubMed Web of Science ®Google Scholar
• Norberg M, Wall S, Boman K, et al. The Västerbotten Intervention Programme: background, design and implications. Glob Health Action. 2010;3:1–15.
   Web of Science ®Google Scholar
• Eriksson M, Holmgren L, Janlert U, et al. Large improvements in major cardiovascular risk factors in the population of northern Sweden: the MONICA study 1986–2009. J Intern Med. 2011;269(2):219–231.
   PubMed Web of Science ®Google Scholar
• Hallmans G, Ågren A, Johansson G, et al. Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort – evaluation of risk factors and their interactions. Scand J Public Health Suppl. 2003;61:18–24.
   PubMedGoogle Scholar
• Ljungberg J, Holmgren A, Bergdahl IA, et al. Lipoprotein(a) and the apolipoprotein B/A1 ratio independently associate with surgery for aortic stenosis only in patients with concomitant coronary artery disease. J Am Heart Assoc. 2017;6(12):1–11.
   Web of Science ®Google Scholar
• Ljungberg J, Johansson B, Engstrom KG, et al. Traditional cardiovascular risk factors and their relation to future surgery for valvular heart disease or ascending aortic disease: a case-referent study. J Am Heart Assoc. 2017;6(5):1–12.
   Web of Science ®Google Scholar
• Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Report of a WHO/IDF consultation. Geneva: World Health Organization; 2006. p. 1–3.
   Google Scholar
• Grubb A, Horio M, Hansson LO, et al. Generation of a new cystatin C-based estimating equation for glomerular filtration rate by use of 7 assays standardized to the international calibrator. Clin Chem. 2014;60(7):974–986.
   PubMed Web of Science ®Google Scholar
• Nyman U, Grubb A, Larsson A, et al. The revised Lund-Malmo GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population. Clin Chem Lab Med. 2014;52(6):815–824.
   PubMed Web of Science ®Google Scholar
• Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29(3):630–634.
   PubMed Web of Science ®Google Scholar
• Yan AT, Koh M, Chan KK, et al. Association between cardiovascular risk factors and aortic stenosis: the CANHEART Aortic Stenosis Study. J Am Coll Cardiol. 2017;69(12):1523–1532.
   PubMed Web of Science ®Google Scholar
• Redfors B, Furer A, Lindman BR, et al. Biomarkers in aortic stenosis: a systematic review. Struct Heart. 2017;1(1–2):18–30.
   Web of Science ®Google Scholar
• Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–2791.
   PubMed Web of Science ®Google Scholar
• Almen MS, Björk J, Nyman U, et al. Shrunken pore syndrome is associated with increased levels of atherosclerosis-promoting proteins. Kidney Int Rep. 2019;4:67–79.
   PubMed Web of Science ®Google Scholar
• Herou E, Dardashti A, Nozohoor S, et al. The mortality increase in cardiac surgery patients associated with shrunken pore syndrome correlates with the eGFRcystatin C/eGFRcreatinine-ratio. Scand J Clin Lab Invest. 2019;79(3):167–173.
   PubMed Web of Science ®Google Scholar
• Moody WE, Edwards NC, Madhani M, et al. Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: cause or association? Atherosclerosis. 2012;223(1):86–94.
   PubMed Web of Science ®Google Scholar
• Kumar Jha P, Ete T, Malviya A, et al. Microalbuminuria: correlation with prevalence and severity of coronary artery disease in non-diabetics. J Clin Med Res. 2017;9(10):838–843.
   PubMedGoogle Scholar
• Huddam B, Azak A, Kocak G, et al. The relationship between serum fetuin-A, cystatin-C levels, and microalbuminuria in patients with metabolic syndrome. J Clin Lab Anal. 2013;27(4):317–322.
   PubMed Web of Science ®Google Scholar
• Ying X, Jiang Y, Qin G, et al. Association of body mass index, waist circumference, and metabolic syndrome with serum cystatin C in a Chinese population. Medicine. 2017;96(10):e6289.
   PubMed Web of Science ®Google Scholar
• Medeiros T, do Rosario NF, Gama NA, et al. Metabolic syndrome components and estimated glomerular filtration rate based on creatinine and/or cystatin C in young adults: a gender issue? Diabetes Metab Syndr. 2017;11(1):S351–S357.
   PubMedGoogle Scholar
• Magnusson M, Molvin J, Engstrom G, et al. Cystatin C and risk of diabetes and the metabolic syndrome – biomarker and genotype association analyses. PLoS ONE. 2016;11(5):e0155735.
   PubMed Web of Science ®Google Scholar
• Skaug EA, Madssen E, Aspenes ST, et al. Cardiovascular risk factors have larger impact on endothelial function in self-reported healthy women than men in the HUNT3 Fitness study. PLoS One. 2014;9(7):e101371.
   PubMed Web of Science ®Google Scholar
• Glader CA, Birgander LS, Söderberg S, et al. Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis. Eur Heart J. 2003;24(2):198–208.
   PubMed Web of Science ®Google Scholar
• Söderberg S, Stegmayr B, Stenlund H, et al. Leptin, but not adiponectin, predicts stroke in males. J Intern Med. 2004;256(2):128–136.
   PubMed Web of Science ®Google Scholar
• Grubb A, Björk J, Nyman U, et al. Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation. Scand J Clin Lab Invest. 2011;71(2):145–149.
   PubMed Web of Science ®Google Scholar